Sahika Cingir Koker

4PUBLICATIONS
4CO-AUTHORS
BiomaterialsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2026
Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword.

Irem Dogan Turacli, Sahika Cingir Koker, Kubra Paspal Eroglu

|Jul 18, 2025
The effects of hsa-mir-26a-5p on cell proliferation, migration, and PI3K inhibitor sensitivity in metformin-resistant triple negative breast cancer cells.

Şahika Cingir Köker, Senem Noyan, Banu Yalçin

|Mar 31, 2022
Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity.

Sahika Cingir Koker, Banu Yalcin, Irem Dogan Turacli

Pageof 1